Skip to content

Multi-National Studies

Data availability is crucial to advance scientific knowledge, diagnosis and management of cardiovascular diseases (CVDs). The World Heart Observatory is compiling high quality registries and epidemiological studies on various forms of CVDs from around the world. In the coming days, users will enable to explore the data from these studies through interactive visualisations as well as have access to the original studies and publications.

Keep an eye out on this space and our social media channels for updates.

Details on the INTERASPIRE study are now available below!

Our Multi-National Studies

The International Action on Secondary Prevention through Intervention to Reduce Event (INTERASPIRE)

Adults with known cardiovascular conditions, such as coronary heart disease, are at a higher risk for further cardiovascular events. Several secondary prevention guidelines and recommendations have been created, which emphasize evidence-based lifestyle and pharmacological treatment. The World Heart Federation has also recently updated its secondary prevention roadmap, detailing strategies for improving secondary prevention at all levels of the health system.

INTERASPIRE is an international study covering 14 countries across the 6 World Health Organization (WHO) regions. It is designed to measure if the guideline standards for secondary prevention and cardiac rehabilitation are being achieved in a timely manner in patients with coronary heart disease.

INTERASPIRE demonstrates inadequate and heterogenous international implementation of guideline standards for secondary prevention in the first year after hospitalization for coronary heart disease and shows geographic and sex disparity. Investment aiming to reduce between-country and between-individual variability in secondary prevention will promote equity in global efforts to reduce the burden of coronary heart disease.

INTERASPIRE. Coronary Heart Disease Patients: 14 Countries from all 6 WHO Regions. 4548 participants Enrolled 2023 - 2023. Secondary Prevention Guideline Targets Assessed a Median 1 Year after Index Event. 13% Active Smoking. 67% not at PA Target. 41% Central Obesity. 67% Dysglycaemia (DM or IFG). 83% LDLc >= 1.4 mmol/L. 61% BP >= 130/80 mmHg. 91% Did Not Attend* Cardiac Rehabilitation.

For more information on the study, please refer to the information below. Further interactive data visualizations to be available soon!

 

With the support of